Salute e Benessere

Dark Horse Consulting Group Acquires BioTechLogic, Inc.

Combined organization to offer strategic advisory, operations, and technical consulting across the biopharma industry Dark Horse Consulting Group(“DHC”), the longstanding global leader in strategic and operational consulting in the field of cell and gene therapy (“CGT”), is delighted to announce the acquisition ofBioTechLogic, Inc.(“BioTechLogic”), a recognized forerunner in technical operations, manufacturing, quality, and regulatory CMC consulting. This strategic acquisition marks a...
Nasdaq GlobeNewswire
03/10/2024

Clinical Trial Imaging Market to Hit USD 2.07 Billion by 2029 with 7.8% CAGR |…

Browse in-depth TOC on "Clinical Trial Imaging Market" Browse in-depth TOC on "Clinical Trial Imaging Market" 311 - Tables 48 - Figures 248 - Pages The clinical trial imaging market is divided into two segments: services and software. By far the largest share of the clinical trial imaging market in 2023 belonged to the services segment. One of the main reasons for this segment's considerable domination is the high cost of imaging equipment. This element has fueled the trend…
PR Newswire
03/10/2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2024

Sales in Zinzino's sales markets increased by 22% in the third quarter of 2024 compared with the same period last year and amounted to SEK 503.9 (413.8) million. Total revenues in the Group increased by 22 % in the third quarter and amounted to SEK 531.9 (436.9) million. Sales in Zinzino's sales markets increased by 22% in the third quarter of 2024 compared with the same period last year and amounted toSEK 503.9(413.8) million. Total revenues in the Group increased by 22 % in the third...
PR Newswire
03/10/2024

Dental Drills & Burs Market Set for Significant Expansion Projected to Reach USD…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1043749 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1043749 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Dental Drills & Burs Market Overview Geographic Dominance : The Dental Drills & Burs Market displays notable geographic dominance across various regions, each contributing uniquely to the market's growth. North...
PR Newswire
03/10/2024

IBC launches RadSep, Inc.: Best-in-class, highly selective separations using…

MRT™ ligands are tailored to target specific ions in terms of matching their shapes and co-ordination chemistry. These molecules are covalently attached to support materials such as organic polymers or silicates to create reusable MRT™ resins that bind metals with exceptional selectivity in packed column mode, including radioisotopes of radium, lead, thorium, actinium, bismuth, copper and others. The bound target radioisotope is removed via elution with very high rates of purity and recovery, up…
PR Newswire
03/10/2024

Medical Grade Silicone Market Surges to USD 3.6 Billion by 2030, Propelled by…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=629644 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=629644 Browse in-depth TOC onMedical Grade Silicone Market 202 – Pages 126 – Tables 37 – Figures Scope of The Report Global Medical Grade Silicone Market Overview Market Drivers Fueling Growth in the Medical Grade Silicone Market Increasing Demand for Medical Devices and Implants The...
PR Newswire
03/10/2024

Custom Foot Orthotic Insoles Market Projected to Reach $5.2 Billion by 2031…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1042869 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1042869 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Custom Foot Orthotic Insoles Market Overview 1.Market Size and Growth : The global Custom Foot Orthotic Insoles Market is poised for significant expansion, with projections indicating a rise from approximatelyUSD 3...
PR Newswire
03/10/2024

Hip Replacement Implants Market is expected to generate a revenue of USD 8.44…

With the increasing prevalence of osteoarthritis, trauma, and bone degeneration, the demand for hip replacement implants has surged globally, making it a key focus area for healthcare providers, medical device manufacturers, and suppliers. Our latest report offers a detailed examination of market dynamics, cutting-edge technologies, regulatory challenges, and strategic growth opportunities. With the increasing prevalence of osteoarthritis, trauma, and bone degeneration, the demand for hip...
PR Newswire
03/10/2024

Coronado Research announce engagement of Rob Nichols to support the growth of…

Nichols commented, "Andrew and I met at an industry event many years ago, and our paths have crossed ever since. We both sat on the board of the Association for Clinical Data Management together and then held senior leadership roles in pharma services and technology companies, at times partnering to provide technology-enabled solutions. It is very exciting to have the opportunity to support Andrew and his team in developing an industry-leading approach to optimising clinical development…
PR Newswire
03/10/2024

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's…

Click here to view the custom infographic of the Annovis Bio editorial. Clickhere to view the custom infographic of the Annovis Bio editorial. Buntanetap Targeting Alzheimer's Disease Annovis Bio Inc. (NYSE: ANVS) is leading efforts to develop innovative and safe treatments for neurodegenerative diseases such as Alzheimer's. The company's main focus is enhancing nerve cell health to improve cognition in such conditions, a target that has proved elusive for peers. The company's...
PR Newswire
03/10/2024

Teva and mAbxience Expand Strategic Partnership to include an additional…

The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024The collaboration supports Teva's Pivot to Growth strategy and adds to the company's biosimilar portfolio Both companies reaffirm their shared commitment to making high-quality, affordable treatments accessible to patients worldwide TEL AVIV, ISRAEL and MADRID, Oct.03, 2024(GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a...
Nasdaq GlobeNewswire
03/10/2024

Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring…

DSMC has reviewed the safety and pharmacokinetic data from Cohort 2 and recommended that the study proceed to enroll patients into Cohort 3 /2a randomized, double-blinded, placebo-controlled clinical trial of SYN-004 (ribaxamase) in allogeneic hematopoietic cell transplant (HCT) recipients for the prevention of acute graft-versus-host-disease (aGVHD).Cohort 2 enrolled 19 patients who received at least 1 dose of study drug (SYN-004 or Placebo randomized 2:1). Eighteen (18) patients received...
Nasdaq GlobeNewswire
03/10/2024

Recent clinical data confirms significantly improved predictive power of…

Improved precision of the AI-Immunology™ platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates The improvement has been achieved through iterative learning and the integration of advanced bioinformatics and machine learning techniquesIn the ongoing phase 2 trial with personalized cancer vaccine EVX-01, 79% of the AI-Immunology™ predicted vaccine targets triggered a tumor-specific immune response, a significant...
Nasdaq GlobeNewswire
03/10/2024

Virbac : Declaration of the number of shares and voting rights 09/2024

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsSeptember, 30 20248 390 660Gross total of voting...
Nasdaq GlobeNewswire
03/10/2024

Pioneering hospitals take major steps towards decarbonizing healthcare with…

Philips helps healthcare organizations worldwide assess and mitigate their environmental impact while enabling better care and better care outcomes for more patients at lower costAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced significant greenhouse gas (GHG) emissions reduction results following collaboration with customers worldwide to assess and mitigate their carbon footprints, while also enhancing patient...
Nasdaq GlobeNewswire
03/10/2024

Atomic Antibiotics Developed by Czech Scientists Counter Bacterial Resistance

A Frontal Attack with Manganese A Frontal Attack with Manganese In developing this antibiotic, the scientists drew on their expertise in graphene chemistry and atomic engineering, fields they have extensively studied in recent years. This time, they utilized a graphene derivative enriched with oxygen and nitrogen atoms, chemically incorporating manganese—a transition metal that is involved in metabolism, bone formation, blood sugar regulation and cellular protection against oxidative...
PR Newswire
03/10/2024

Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.Per October 1, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,534,358 shares, corresponding to 5.02% (previously 4.97%) of the total share capital attached to shares. The combined total of share...
Nasdaq GlobeNewswire
03/10/2024

Positrigo Secures CE Mark in Europe for its Pioneering Dedicated Brain PET…

"The CE mark of the NeuroLF system is another important milestone in the development of this dedicated brain PET system and represents a significant advance in the availability of brain PET imaging, allowing nuclear medicine physicians in Europe to offer a dedicated imaging modality to diagnose and monitor patients with brain related disorders", says Prof. Dr. med. Osama Sabri, Director and Chairman of the Department of Nuclear Medicine at the University of Leipzig Medical Center…
PR Newswire
03/10/2024

Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair…

Paul Sekhri, seasoned life sciences executive with decades of drug development and extensive business development experience, appointed Chair of the Board of Directors Paul Sekhri, seasoned life sciences executive with decades of drug development and extensive business development experience, appointed Chair of the Board of Directors EDINBURGH, ScotlandandLONDON,Oct. 3, 2024/PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical...
PR Newswire
03/10/2024

Veritas Genetic participates in a groundbreaking study highlighting the…

Key Findings of the Study Key Findings of the Study The study, published in the Journal of Personalized Medicine, evaluated women with a family history of breast cancer, demonstrating that PRS significantly improves the accuracy of individual risk prediction. This is particularly relevant for women who are non-carriers of pathogenic variants in susceptibility genes. For carriers of mutations in genes likeBRCA1andBRCA2, PRS offers a complementary approach that helps refine...
PR Newswire
03/10/2024

XRP Healthcare and Foventa Collaborate for Africa's Premier Lab Expo

This partnership aligns with XRP Healthcare's broader strategy to advance healthcare innovation, particularly in artificial intelligence (AI). The company recently established a dedicated AI team to pioneer advancements in healthcare AI, positioning itself at the forefront of AI integration in diagnostics, patient care, and medical research throughoutAfrica. In conjunction with the event, XRP Healthcare is set to unveil the much-anticipated fourth edition ofXRP Healthcare...
PR Newswire
03/10/2024

Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00…

Saint Herblain (France), October 3, 2024 – Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will host an investor day at the Lotte New York Palace Hotel in New York, NY on Thursday, October 10, 2024 at 10:00 AM ET (4:00 pm CET). The meeting will be conducted in a hybrid way – in person and webcast. To register,click here.The event will focus on Valneva's robust R&D pipeline of potentially first-, only-, or best-in-class vaccine...
Nasdaq GlobeNewswire
03/10/2024

IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create…

A EUR 16 million Initiative to Establish Strategic EU Autonomy in Alpha Therapies for Cancer Louvain-la-Neuve, Belgium , October 3, 2024– IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of radiopharmaceutical production solutions, is pleased to announce that the European Commission has approved the financing of the Accelerate.EU project launching on October 1, 2024. IBA's key role in this new project...
Nasdaq GlobeNewswire
03/10/2024

New data indicates use of 3D specimen tomosynthesis can improve breast cancer…

"The MOZART System with its tomosynthesis imaging technology gives us immediate and highly detailed 3D information, which allows us to make more precise surgical decisions," remarked Dr. Kothari. "Reducing repeat surgeries is a huge benefit for patients and healthcare systems." "The MOZART System with its tomosynthesis imaging technology gives us immediate and highly detailed 3D information, which allows us to make more precise surgical decisions," remarked Dr…
PR Newswire
03/10/2024
Altri  Comunicati